NCT04742660View on ClinicalTrials.gov

The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting

NACompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

March 8, 2022

Study Completion Date

March 10, 2022

Conditions
Postoperative Nausea
Interventions
DRUG

Ammonium Glycyrrhizinate

In control group, we assess the incidence and severity of PONV when participants are aministered ramosetron and placebo. In intervention group, the outcomes are assessed as a result of administration of ramosetron and glycyrrhizin.

Trial Locations (1)

05030

Konkuk University Medical Center, Seoul

All Listed Sponsors
lead

Konkuk University Medical Center

OTHER